These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 20970216)

  • 21. Prognostic significance of osteopontin in hepatitis B virus-related hepatocellular carcinoma.
    Xie H; Song J; Du R; Liu K; Wang J; Tang H; Bai F; Liang J; Lin T; Liu J; Fan D
    Dig Liver Dis; 2007 Feb; 39(2):167-72. PubMed ID: 17161983
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of osteopontin and CD44s expression for patients with hepatocellular carcinoma undergoing liver transplantation or resection.
    Beckebaum S; Chen X; Sotiropoulos GC; Radtke A; Daoudaki M; Baba HA; Wohlschlaeger J; Broelsch CE; Gerken G; Cicinnati VR
    Transplant Proc; 2008 Nov; 40(9):3182-4. PubMed ID: 19010227
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Late recurrence of hepatocellular carcinoma after liver transplantation: is an active surveillance for recurrence needed?
    Castroagudín JF; Molina-Pérez E; Ferreiro-Iglesias R; Abdulkader I; Otero-Antón E; Tomé S; Varo-Pérez E
    Transplant Proc; 2012; 44(6):1565-7. PubMed ID: 22841215
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between hepatitis B and hepatocellular carcinoma recurrence in patients undergoing liver transplantation.
    Kiyici M; Yilmaz M; Akyildiz M; Arikan C; Aydin U; Sigirli D; Nart D; Yilmaz F; Ozacar T; Karasu Z; Kilic M
    Transplant Proc; 2008 Jun; 40(5):1511-7. PubMed ID: 18589140
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness of locoregional therapy before living donor liver transplantation in patients with hepatocellular carcinoma who meet the Milan criteria.
    Kim JM; Kwon CH; Joh JW; Choi MS; Lee JH; Koh KC; Paik SW; Kim GS; Kim SJ; Lee SK; Yoo BC
    Transplant Proc; 2012 Mar; 44(2):403-8. PubMed ID: 22410028
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of clinical outcomes in chronic hepatitis B liver transplant candidates with and without hepatocellular carcinoma.
    Wong SN; Reddy KR; Keeffe EB; Han SH; Gaglio PJ; Perrillo RP; Tran TT; Pruett TL; Lok AS
    Liver Transpl; 2007 Mar; 13(3):334-42. PubMed ID: 17154401
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liver transplantation for hepatocellular carcinoma: results of a multicenter study with common priorization criteria.
    Santoyo J; Sanchez B; de la Mata M; Fernández-Aguilar JL; Lopez-Ciller P; Pascasio JM; Suarez MA; Gomez MA; Nogueras F; Muffak K; Cuende N; Alonso M
    Transplant Proc; 2009 Apr; 41(3):1009-11. PubMed ID: 19376412
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Younger age and presence of macrovascular invasion were independent significant factors associated with poor disease-free survival in hepatocellular carcinoma patients undergoing living donor liver transplantation.
    Wai CT; Woon WA; Tan YM; Lee KH; Tan KC
    Transplant Proc; 2012 Mar; 44(2):516-9. PubMed ID: 22410059
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of histological grade of hepatocellular carcinoma on the outcome of liver transplantation.
    Tamura S; Kato T; Berho M; Misiakos EP; O'Brien C; Reddy KR; Nery JR; Burke GW; Schiff ER; Miller J; Tzakis AG
    Arch Surg; 2001 Jan; 136(1):25-30; discussion 31. PubMed ID: 11146770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatocyte nuclear factor 1β is a novel prognostic marker independent of the Milan criteria in transplantable hepatocellular carcinoma: a retrospective analysis based on tissue microarrays.
    Shim JH; Lee HC; Han S; Kang HJ; Yu E; Lee SG
    Liver Transpl; 2013 Mar; 19(3):336-45. PubMed ID: 23203386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recurrence and poor prognosis following resection of small hepatitis B-related hepatocellular carcinoma lesions are associated with aberrant tumor expression profiles of glypican 3 and osteopontin.
    Yu MC; Lee YS; Lin SE; Wu HY; Chen TC; Lee WC; Chen MF; Tsai CN
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S455-63. PubMed ID: 21822558
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis C.
    Shimoda M; Ghobrial RM; Carmody IC; Anselmo DM; Farmer DG; Yersiz H; Chen P; Dawson S; Durazo F; Han S; Goldstein LI; Saab S; Hiatt J; Busuttil RW
    Liver Transpl; 2004 Dec; 10(12):1478-86. PubMed ID: 15558585
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Orthotopic liver transplantation for hepatocellular carcinoma: a thirteen-year single-center experience.
    Castroagudín JF; Molina E; Bustamante M; Tomé S; Otero E; Martínez J; Segade FR; Conde R; Varo E
    Transplant Proc; 2008 Nov; 40(9):2975-7. PubMed ID: 19010164
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microvascular tumor embolism: independent prognostic factor after liver transplantation in hepatocellular carcinoma.
    Lee HH; Joh JW; Park JH; Lee KW; Heo JS; Choi SH; Kim SJ; Lee SK
    Transplant Proc; 2005 Mar; 37(2):1251-3. PubMed ID: 15848686
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumour size is an important predictor for the outcome after liver transplantation for hepatocellular carcinoma.
    Löhe F; Angele MK; Gerbes AL; Löhrs U; Jauch KW; Schauer RJ
    Eur J Surg Oncol; 2005 Nov; 31(9):994-9. PubMed ID: 16076546
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expanded criteria for liver transplantation in patients with cirrhosis and hepatocellular carcinoma.
    Silva M; Moya A; Berenguer M; Sanjuan F; López-Andujar R; Pareja E; Torres-Quevedo R; Aguilera V; Montalva E; De Juan M; Mattos A; Prieto M; Mir J
    Liver Transpl; 2008 Oct; 14(10):1449-60. PubMed ID: 18825681
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selection criteria for liver transplantation in early-stage hepatocellular carcinoma with cirrhosis: results of a multicenter study.
    Figueras J; Ibañez L; Ramos E; Jaurrieta E; Ortiz-de-Urbina J; Pardo F; Mir J; Loinaz C; Herrera L; López-Cillero P; Santoyo J
    Liver Transpl; 2001 Oct; 7(10):877-83. PubMed ID: 11679986
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The significance of MMP-9 over MMP-2 in HCC invasiveness and recurrence of hepatocellular carcinoma after curative resection.
    Chen R; Cui J; Xu C; Xue T; Guo K; Gao D; Liu Y; Ye S; Ren Z
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S375-84. PubMed ID: 21681378
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Living-donor liver transplantation for hepatocellular carcinoma.
    Kaihara S; Kiuchi T; Ueda M; Oike F; Fujimoto Y; Ogawa K; Kozaki K; Tanaka K
    Transplantation; 2003 Feb; 75(3 Suppl):S37-40. PubMed ID: 12589138
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The timing of liver transplantation after primary hepatectomy for hepatocellular carcinoma: a special reference to recurrence pattern and Milan criteria.
    Ikegami T; Shimada M; Imura S; Yoshizumi T; Arakawa Y; Tokunaga T; Morine Y; Kanemura H
    Transplantation; 2008 Sep; 86(5):641-6. PubMed ID: 18791443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.